Recruiting Pulmonary Embolism Studies in Yuma
A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. ...
A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants who...
About Pulmonary Embolism Clinical Trials in Yuma
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Yuma, AZ. These studies are seeking a combined 12,160 participants. Research is being sponsored by Boehringer Ingelheim, Carmot Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Yuma — FAQ
Are there pulmonary embolism clinical trials in Yuma?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Yuma, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Yuma?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Yuma research site will contact you about next steps.
Are clinical trials in Yuma free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Yuma studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Yuma are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov